Navigation Links
Bioniche Pharma Launches Ibutilide Fumarate Injection
Date:1/12/2010

LAKE FOREST, Ill., Jan. 12 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals announced today the launch of Ibutilide Fumarate Injection, the generic equivalent of Corvert® from Pfizer Inc.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO)

"The addition of Ibutilide Fumarate Injection further demonstrates Bioniche Pharma's continued growth and dedication to a consistently expanding portfolio of injectables," said George Zorich, President, US Operations for Bioniche Pharma.

Bioniche Pharma will supply Ibutilide Fumarate Injection in 0.1 mg/mL, 10mL vials.

This product has a boxed warning relating to proarrhythmic effects including potentially fatal arrhythmias (e.g., polymorphic ventricular tachycardia) and consideration for use in patients with chronic atrial fibrillation. Please refer to the Bioniche Pharma website at www.bionichepharma.com for the complete prescribing information for this product, including the boxed warning.

About Bioniche Pharma:

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets. The company's growth is fueled by an internal development pipeline and an aggressive acquisition strategy for products. Bioniche Pharma was acquired in February 2006 by RoundTable Healthcare Partners, a private equity firm based in
'/>"/>

SOURCE Bioniche Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
2. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
3. Bioniche Pharma and Academic Pharmaceuticals, Inc. Announce the Introduction of Sotalol Hydrochloride Injection
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... YORK and LONDON , ... of market intelligence, MarketResearch.com is pleased to announce the ... and Consultancy focusing on the active pharmaceutical ingredient (API) ... visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In IQ4I,s ... – Forecast to 2020 , IQ4I ...
(Date:11/26/2014)...  Medtronic,s roughly $43 billion acquisition and ... in the media for its US Federal tax ... player in one of the fastest growing device ... research firm said  the two companies compete in ... of solutions spanning inpatient to home care, and ...
(Date:11/26/2014)... 25, 2014  Breckenridge Pharmaceutical, Inc. announced today ... agreement with Pii (Pharmaceutics International, Inc.) ( ... and Pii expect to develop and commercialize several ... Pii will develop, manufacture and supply the products, ... under its own label.  The drugs, comprised of ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Dendreon Corporation (Nasdaq: DNDN ) announced ... approved the remainder of its New Jersey manufacturing facility, ... PROVENGE® (sipuleucel-T) to help meet the needs of patients ... refractory) prostate cancer.   Last April, upon ...
... drug used to treat erectile dysfunction and pulmonary ... and young adults with congenital heart disease to ... exercise performance during stress testing in patients with ... Children,s Hospital of Philadelphia. This study ...
Cached Medicine Technology:Dendreon Expands Launch of PROVENGE 2Dendreon Expands Launch of PROVENGE 3Dendreon Expands Launch of PROVENGE 4Dendreon Expands Launch of PROVENGE 5Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction 2Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction 3
(Date:11/26/2014)... the well-known wedding dress manufacturer for the global market, ... for ladies worldwide. Meanwhile, these graceful items are offered ... very popular in the world and clients can buy ... , Sweetdressy.com believes that a company can attract clients ... best services. The spirit of the company is making ...
(Date:11/26/2014)... Norwalk Hospital is pleased to announce ... the American Nurses Credentialing Center (ANCC). , The ... work environments where nurses can flourish. The designation ... Hospital and identifies it as one of the ... organizations’ commitment to nurses and their contributions toward ...
(Date:11/26/2014)... -- When you,re planning your holiday get-away, don,t ... sports -- such as skiing or hiking, a ... may fail to take altitude into account when ... risk of developing fatigue and other symptoms related ... Dr. Melissa Tabor, an assistant professor of sports ...
(Date:11/26/2014)... Reinberg HealthDay Reporter WEDNESDAY, ... smoking cigarettes than ever, health officials said. In fact, ... percent in 2005 to 18 percent in 2013. That means ... 42.1 million, despite the increasing population, according to the U.S. ... still have a long way to go, and if we ...
(Date:11/26/2014)... The family foundation of Best Buy founder, Richard ... Foundation (Meso Foundation), half of which will be specifically ... Program . The focus area of the Richard M. ... organizations that can generate transformational results in education, human ... and chairman emeritus of Best Buy Co., Inc., the ...
Breaking Medicine News(10 mins):Health News:Cheap Prom Dresses For Ladies Introduced At SweetDressy.com 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 3Health News:Don't Let High Altitude Ruin Your Holiday Trip 2Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 2Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 3Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 2Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 3
... Vereen Issues a Call-to-Action for People with Diabetes to ... Diabetes Today, BRIDGEWATER, N.J., Sept. 24 Tony,Award-winning ... a world leader in diabetes care, to launch Take ... to educate,people living with diabetes about their condition. Since ...
... Age 55 and Over to Know the Signs,of ... Suspected, WASHINGTON, D.C., Sept. 24 Despite ... detection, there are,striking differences between intentions and actual ... adults age 55 and over titled, "Alzheimer,s,Disease: Current ...
... Launch of the Disposable flexfit (TM) Breaks down Longstanding Barriers to ... ... N.J., Sept. 24 Songbird Hearing, Inc.,today introduces a unique option ... that 55 million Americans currently,experience some degree of hearing loss, while ...
... Hospital Assets,Patient Care to Remain Uninterrupted At HPA Hospitals, ... America,("HPA" or "the Company") announced today that it and ... Chapter 11,of the U.S. Bankruptcy Code. The filings do ... the HPA system, which continue to operate as usual.,The ...
... The 2008 Compensation Data survey results found that 67.3 percent ... and their family. , ... Kansas ... increases, employers and employees continue to see high health insurance ...
... Drug Administration,s (FDA,s) plan to list those drugs whose safety is ... drug companies, physicians, and patients. , ... Horsham, PA ... the Food and Drug Administration,s (FDA,s) plan to list those drugs ...
Cached Medicine News:Health News:Ben Vereen, Tony Award-Winning Actor, Strives to Raise Awareness of Diabetes and Treatment 2Health News:Ben Vereen, Tony Award-Winning Actor, Strives to Raise Awareness of Diabetes and Treatment 3Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 2Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 3Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 4Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 5Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 2Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 3Health News:Corporate Parent Hospital Partners of America Files Voluntary Chapter 11 Petition; Filings do not Include any Hospital Facilities 2Health News:Health Insurance Premium Costs High for Employers and Employees 2Health News:DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation 2